Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Hashimoto

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Japanese Journal of Clinical Oncology|March 6, 2026
Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR studyYukiya Narita, Hisato Kawakami, Koki Nakanishi, et al.
Circulation Reports|September 12, 2025
Differences in P2Y<sub>12</sub> Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes　- Subanalysis From ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 18, 2025
P2Y<sub>12</sub> Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 24, 2025
CORRIGENDUM: P2Y<sub>12</sub> Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Journal of Atherosclerosis and Thrombosis|March 4, 2026
P2Y<sub>12</sub> Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS StudyShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Japanese Journal of Clinical Oncology|March 6, 2026
Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR studyYukiya Narita, Hisato Kawakami, Koki Nakanishi, et al.
Circulation Reports|September 12, 2025
Differences in P2Y<sub>12</sub> Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes　- Subanalysis From ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 18, 2025
P2Y<sub>12</sub> Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 24, 2025
CORRIGENDUM: P2Y<sub>12</sub> Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRASShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Journal of Atherosclerosis and Thrombosis|March 4, 2026
P2Y<sub>12</sub> Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS StudyShigeru Fujimoto, Yasuyuki Iguchi, Hiroshi Yamagami, et al.
Pageof 17